Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Factor 5A1 induces apoptosis in lung cancer mice study

April 14, 2004

Access' AP-5346 shows greater Pt delivery to tumor DNA than oxaliplatin

April 14, 2004

Novel camptothecin derivatives with enhanced stability and antitumor activity

April 14, 2004

KS-119, a potential hypoxic cell cytotoxin

April 14, 2004

ON-1910Na effective against human liver cancer in vivo

April 14, 2004

FASgen receives NCI grant to support study of FAS inhibitors

April 13, 2004

Novel Bcl-XL antagonist effective against chemoresistant cancers in vivo

April 13, 2004

Enhanced tumor cytotoxicity with novel DNA-PK inhibitor

April 13, 2004

Novel small molecule tubulin inhibitor by Zentaris

April 13, 2004

New gossypol analogues and their use in cancer therapy reported by CNRS

April 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...